EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery
Conclusions
Combining EuroSCORE II and preoperative NT-proBNP appears to improve risk prediction with regard to severe circulatory failure after isolated CABG for ACS. NT-proBNP may be particularly useful in patients at intermediate risk according to EuroSCORE II.
Clinical trial registration
NCT00489827.
Source: British Journal of Anaesthesia - Category: Anesthesiology Authors: Holm, J., Vidlund, M., Vanky, F., Friberg, O., Hakanson, E., Walther, S., Svedjeholm, R. Tags: Cardiovascular Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Coronary Artery Bypass Graft | Heart | Heart Failure | Intensive Care | Renal Failure | Stroke | Study